Cytoskeletal reorganization induced by retinoic acid treatment of human endometrial adenocarcinoma (RL95-2) cells is correlated with alterations in protein kinase C-α

Pathobiology

Volumn 66, Issue 6, 1998, Pages 284-292

  Carter, Charleata A ^a   Parham, Groesbeck P ^a   Chambers, Timothy ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adenocarcinoma; Differentiation; Endometrium; F actin; Protein kinase C; Retinoids

Indexed keywords

ACTIN; BISINDOLYLMALEIMIDE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RETINOIC ACID; STAUROSPORINE;

ACTIN FILAMENT; ARTICLE; CANCER CELL CULTURE; CELL SHAPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSKELETON; ENDOMETRIUM CARCINOMA; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CARBAZOLES; CELL DIFFERENTIATION; CYTOSKELETON; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLES; ISOENZYMES; MALEIMIDES; PHENOTYPE; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; STAUROSPORINE; TRETINOIN; TUMOR CELLS, CULTURED; UTERINE NEOPLASMS;

EID: 0031656178     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028035     Document Type: Article

References (52)

1. Roberts AB, Sporn MB: Cellular biology and biochemistry of the retinoids; in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids. New York, Academic Press, 1984, vol 2, pp 210-286.
2. Brockes JP: Retinoids, homeobox genes, and limb morphogenesis. Neuron 1989;2:1285-1294.
3. Kopan R, Fuchs E: The use of retinoic acid to probe the relation between hyperproliferation-associated keratins and cell proliferation in normal and malignant epidermal cells. J Cell Biol 1989;109:295-307.
4. De Luca LM: Retinoids and their receptors in differentiation, embryogenesis and neoplasia. FASEB J 1991;5:2924-2933.
5. Maden M. Role of retinoids in embryonic development: in Blomhoff R (ed): Vitamin A in Health and Disease. New York, Marcel Dekker, 1994, pp 289-322.
6. Chambon P: The retinoid signalling pathway: Molecular and genetic analyses. Semin Cell Biol 1994;5:115-125.
7. Bakke O, Espevik T: Retinoic acid induces a specific membrane glycoprotein in human epithelial cell lines. Exp Cell Res 1989;180:20-29.
8. Budd GT, Gupta M, Ganapathi R, Admason P, Karnik P, Sandatrom K, McLain D, Bukowski RM. Phase I trial of trans-retinoic acid and tamoxifen in advanced breast cancer. Proc Am Assoc Cancer Res 1994;35:229A.
9. Kudelka AP, Freedman RS, Edwards CL, Lippman SM, Tornos CS, Krakoff IH, Kavanagh JJ: Metastatic adenocarcinoma of the endometrium treated with 13-cis-retinoic acid plus interferon-alpha. Anticancer Drugs 1993;4:335-337.
10. Armstrong B, Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1975;15:617-631.
11. Haenszel W, Kurihara M: Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-68.
12. Negri E, Vacchia CL, Franceschi S, Levi F, Parazzini F: Intake of selected micronutrients and the risk of endometrial carcinoma. Cancer 1996;77:917-923.
13. Carter CA, Pogribny M, Davidson A, Jackson CD, McGarrity LJ, Morris SM: Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (RL95-2) cells. Anticancer Res 1996;16:17-24.
14. Nishizuka Y: The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988;334:661-665.
15. Parker P, Kuor G, Marais R, Mitchell F, Pears C, Stabel S, Webster C: Protein kinase C: A family affair. Mol Cell Endocrinol 1989;65:1-11.
16. Nishizuka Y: Studies and perspectives of protein kinase C. Science 1986;233:305-312.
17. Nishizuka Y: The family of protein kinase C for signal transduction. JAMA 1989;262:1826-1833.
18. Woods A, Couchman JR: Protein kinase C involvement in focal adhesion formation. J Cell Sci 1992;101:277-290.
19. Burridge K, Molony L, Kelly T: Adhesion plaques: Sites of transmembrane interaction between the extracellular matrix and the actin cytoskeleton. J Cell Sci 1987:S(suppl):211-229.
20. Geiger B, Volk T, Volberg T, Bendori R: Molecular interactions in adherens-type contacts. J Cell Sci 1987:8(suppl):251-272.
21. Weinstein IB: Growth factors, oncogenes, and multistage carcinogenesis. J Cell Biochem 1987;33:213-224.
22. ++ activated, phospholipid dependent PKC by TPA. J Biol Chem 1982;257:7847-7851.
23. Niedel JE, Kuhn LJ, Vandenbark GR: Phorbol diester receptor copurifies with protein kinase C. Proc Natl Acad Sci USA 1983;80:36-40.
24. Danowski BA, Harris AK: Changes in fibroblast contractility, morphology, and adhesion in response to a phorbol ester tumor promoter. Exp Cell Res 1988;177:47-59.
25. Isakov N, Gopas J, Priel E, Segal S, Altman A: Effect of protein kinase C activating tumor promotors on metastases formation by fibrosarcoma cells. Invasion Metastasis 1991;11:14-24.
26. Lacal JC, Moscat J, Aaronson SA: Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature 1987;330:269-272.
27. Preiss J, Loomis CR, Bishop WR, Stein R, Niedle JE, Bell RM: Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J Biol Chem 1985;261:8596-8600.
28. Wolfman A, Macara IG: Elevated levels of diacylglycerol and decreased phorbol ester sensitivity in ras-transformed fibroblasts. Nature 1987;325:359-361.
29. O'Brian C, Vogel V, Singletary S, Ward E: Elevated protein kinase C expression in human breast tumor biopsies relative to normal breast tissue. Cancer Res 1989;49:3215-3217.
30. Fisher GJ, Esmann J, Griffiths CEM, Talwar HS, Duell EA, Hammerberg C, Elder JT, Karabin GD, Nickoloff BJ, Cooper KD, Voorhees JJ: Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin. J Invest Dermatol 1991;96:699-707.
31. Tonini GP, Parodi MT, Di Martine D, Varesio L: Expression of protein kinase C-alpha (PKC-alpha) and MYCN mRNAs in human neuro-blastoma cells and modulation during morphological differentiation induced by retinoic acid. FEBS Lett 1991;280:221-224.
32. Devalia V, Thomas NS, Roberts PJ, Jones HM, Linch DC: Down-regulation of human protein kinase C alpha is associated with terminal neutrophil differentiation. Blood 1992;80:68-76.
33. Kahl-Ranier P, Marian B: Retinoids inhibit protein kinase C-dependent transduction of 1,2-diglyceride signals in human colonic tumor cells. Nutr Cancer 1994;21:157-168.
34. Gundimeda U, Gopalakrishna R: Retinoids induce a decrease in protein kinase C activity in lung carcinoma cells and suppress invasion and metastasis. Proc Am Assoc Cancer Res 1994;35:335A.
35. Loomis CR, Bell RM: Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C. J Biol Chem 1988;263:1682-1692.
36. ++ dependent protein kinase. Biochem Biophys Res Commun 1986;135:397-402.
37. Watson S, McNally J, Shipman L, Godfrey P: The action of the protein kinase C inhibitor, Staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin. Biochem J 1988;249:345-350.
38. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991;266:15771-15781.
39. Meyer T, Regenass U, Fabbro D, Alteri E, Rösel J, Müller M, Caravan G, Matter A: A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity. Int J Cancer 1989;43:851-856.
40. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marmé D, Schächtele C: Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J Biol Chem 1993;268:9194-9197.
41. Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Mushinski JF: Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-α and δ and not by PKC-βII, ε, ζ and η. J Biol Chem 1993;268:20110-20115.
42. Jaken S, Chapline C, Li Y, Mousseau B: Disrupted PKC signaling in transformed cells. Proc Am Assoc Cancer Res 1997;38:3369A.
43. Carter CA, Rinehart CA, Bagnell CR, Kaufman DG: Fluorescent laser scanning microscopy of F-actin disruption in human endometrial stromal cells expressing the SV40 large T antigen and the El ras oncogene. Pathobiology 1991;59:36-45.
44. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
45. Carter CA, Parham GP: State of differentiation affects the response of endometrial adenocarcinoma cells to retinoic acid. Anticancer Res 1997;17:1973-1984.
46. Hirota K, Hirota T, Aquirela G, Catt KJ: Hormone-induced redistribution of calcium-activated phospholipid-dependent protein kinase in pituitary gonadotrophs. J Biol Chem 1985;260:3245-3246.
47. Jaken S, Leach K, Klauck T: Association of type 3 PKC with focal contacts in rat embryo fibroblasts. J Cell Biol 1989;109:697-704.
48. Way DL, Grosso DS, Davis JR, Surwit EA, Christian CD: Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 1983;19:147-158.
49. Ha genes are mediated by protein kinase C-α. Cancer Res 1994;54:6413-6420.
50. Dena MM, McKay R: Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci USA 1994;91:11762-11766.
51. Lee Y-S, Dlugosz AA, McKay R, Dean NM, Yuspa SH: Definition by specific antsense oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes. Mol Carcinog 1997;18:44-53.
52. Denham DW, Rosemurgy AR, Zervos EE, Franz M, Dean NM, Gower W: PKC-α antisense oligodeoxynucleotide treatment confers a survival benefit in an orthotropic model of pancreatic cancer. Proc Am Assoc Cancer Res 1997;38:2819A.